Display options
Share it on

Front Syst Neurosci. 2013 Nov 27;7:95. doi: 10.3389/fnsys.2013.00095. eCollection 2013.

Decomposition of abnormal free locomotor behavior in a rat model of Parkinson's disease.

Frontiers in systems neuroscience

Benjamin Grieb, Constantin von Nicolai, Gerhard Engler, Andrew Sharott, Ismini Papageorgiou, Wolfgang Hamel, Andreas K Engel, Christian K Moll

Affiliations

  1. Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, University of Hamburg Hamburg, Germany ; Department of General Psychiatry, Center for Psychosocial Medicine, University of Heidelberg Heidelberg, Germany.
  2. Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, University of Hamburg Hamburg, Germany ; Centre for Integrative Neuroscience, University of Tübingen Tübingen, Germany.
  3. Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, University of Hamburg Hamburg, Germany.
  4. Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, University of Hamburg Hamburg, Germany ; Medical Research Council, Anatomical Neuropharacology Unit, Department of Pharmacology, University of Oxford Oxford, UK.
  5. Division of General Neurophysiology, Institute of Physiology and Pathophysiology, University of Heidelberg Heidelberg, Germany.
  6. Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, University of Hamburg Hamburg, Germany.

PMID: 24348346 PMCID: PMC3842038 DOI: 10.3389/fnsys.2013.00095

Abstract

Poverty of spontaneous movement, slowed execution and reduced amplitudes of movement (akinesia, brady- and hypokinesia) are cardinal motor manifestations of Parkinson's disease that can be modeled in experimental animals by brain lesions affecting midbrain dopaminergic neurons. Most behavioral investigations in experimental parkinsonism have employed short-term observation windows to assess motor impairments. We postulated that an analysis of longer-term free exploratory behavior could provide further insights into the complex fine structure of altered locomotor activity in parkinsonian animals. To this end, we video-monitored 23 h of free locomotor behavior and extracted several behavioral measures before and after the expression of a severe parkinsonian phenotype following bilateral 6-hydroxydopamine (6-OHDA) lesions of the rat dopaminergic substantia nigra. Unbiased stereological cell counting verified the degree of midbrain tyrosine hydroxylase positive cell loss in the substantia nigra and ventral tegmental area. In line with previous reports, overall covered distance and maximal motion speed of lesioned animals were found to be significantly reduced compared to controls. Before lesion surgery, exploratory rat behavior exhibited a bimodal distribution of maximal speed values obtained for single movement episodes, corresponding to a "first" and "second gear" of motion. 6-OHDA injections significantly reduced the incidence of second gear motion episodes and also resulted in an abnormal prolongation of these fast motion events. Likewise, the spatial spread of such episodes was increased in 6-OHDA rats. The increase in curvature of motion tracks was increased in both lesioned and control animals. We conclude that the discrimination of distinct modes of motion by statistical decomposition of longer-term spontaneous locomotion provides useful insights into the fine structure of fluctuating motor functions in a rat analog of Parkinson's disease.

Keywords: 6-OHDA lesions; Parkinson disease; spontaneous activity; stereology; video monitoring

References

  1. Brain Res. 1975 Dec 12;100(1):163-9 - PubMed
  2. Nat Rev Neurosci. 2002 Jul;3(7):574-9 - PubMed
  3. Neuropharmacology. 2012 Jun;62(7):2267-77 - PubMed
  4. Exp Neurol. 2013 May;243:45-56 - PubMed
  5. J Neurosci Methods. 2005 Oct 15;148(1):78-87 - PubMed
  6. Science. 1978 Mar 31;199(4336):1461-3 - PubMed
  7. J Microsc. 1986 Jul;143(Pt 1):3-45 - PubMed
  8. Behav Brain Res. 2001 Nov 1;125(1-2):133-40 - PubMed
  9. Prog Neurobiol. 1996 Oct;50(2-3):275-331 - PubMed
  10. Prog Neurobiol. 1996 Jun;49(3):215-66 - PubMed
  11. Exp Neurol. 2010 Feb;221(2):307-19 - PubMed
  12. J Neurosci Methods. 2012 Sep 30;210(2):187-94 - PubMed
  13. Exp Neurol. 2013 May;243:57-66 - PubMed
  14. Nat Rev Neurosci. 2010 Nov;11(11):760-72 - PubMed
  15. Acta Physiol Scand Suppl. 1971;367:69-93 - PubMed
  16. J Neurosci. 2007 Sep 5;27(36):9595-606 - PubMed
  17. Prog Brain Res. 2002;135:43-51 - PubMed
  18. Magn Reson Imaging. 2008 Jun;26(5):594-601 - PubMed
  19. Exp Neurol. 2008 Jun;211(2):413-22 - PubMed
  20. Exp Brain Res. 2009 Mar;193(4):529-44 - PubMed
  21. Anat Rec. 1991 Dec;231(4):482-97 - PubMed
  22. Neurosci Biobehav Rev. 2001 Jul;25(5):409-26 - PubMed
  23. Brain Res. 1994 Jan 7;633(1-2):144-50 - PubMed
  24. Exp Neurol. 2011 Nov;232(1):66-75 - PubMed
  25. Brain Res. 2001 Mar 30;896(1-2):56-63 - PubMed
  26. Science. 1990 Sep 21;249(4975):1436-8 - PubMed
  27. Folia Neuropathol. 1996;34(2):102-6 - PubMed
  28. Brain. 2010 Apr;133(Pt 4):1111-27 - PubMed
  29. Nature. 1988 Jul 28;334(6180):345-8 - PubMed
  30. Behav Brain Res. 2006 Apr 25;169(1):1-9 - PubMed
  31. Brain Res. 2005 Feb 9;1034(1-2):153-61 - PubMed
  32. Physiol Res. 1995;44(3):143-50 - PubMed
  33. J Neurosci Methods. 2000 Mar 15;96(2):119-31 - PubMed
  34. J Neurosci. 2012 Jun 6;32(23):7869-80 - PubMed
  35. Exp Neurol. 1997 Mar;144(1):202-13 - PubMed
  36. Neurology. 1985 Aug;35(8):1215-8 - PubMed
  37. Eur J Neurosci. 2005 Aug;22(3):735-44 - PubMed
  38. Exp Neurol. 1992 Nov;118(2):215-26 - PubMed
  39. J Microsc. 1987 Sep;147(Pt 3):229-63 - PubMed
  40. Brain. 1972;95(3):475-86 - PubMed

Publication Types